HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
1H-Benzimidazole-2-acetic acid → 2-(1H-benzo[d]imidazol-2-yl)-N-(3-fluoro-4-(2-(4-(morpholine-4-carbonyl)phenyl)thieno[3,2-b]pyridin-7-yloxy)phenyl)acetamide
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 1H-Benzimidazole-2-acetic acid | HCID 26117 | — |
| Edukt | (4-(7-(4-Amino-2-fluorophenoxy)thieno[3,2-b]pyridin-2-yl)phenyl)(morpholino)methanone | HCID 67347265 | — |
| Produkt | 2-(1H-benzo[d]imidazol-2-yl)-N-(3-fluoro-4-(2-(4-(morpholine-4-carbonyl)phenyl)thieno[3,2-b]pyridin-7-yloxy)phenyl)acetamide | HCID 58949492 | 6% |
Reaktionsschritte
Prepared from (4-(7-(4-amino-2-fluorophenoxy)thieno[3,2-b]pyridin-2-yl)phenyl)(morpholino)methanone (Example 129, Step A) and 2-(1H-benzo[d]imidazol-2-yl)acetic acid according to the procedure of Example 89. The crude was purified by preparative HPLC to afford the desired product (1.9 mg, 6%). LRMS (ESI pos) m/e 607.9 (M+1). 1H-NMR (400 MHz, CD3OD) δ 8.53 (d, 1H), 7.94 (m, 4H), 7.81 (m, 2H), 7.61 (m, 4H), 7.47 (m, 2H), 6.74 (d, 1H), 3.73 (m, 8H), 3.50 (m, 2H); 19F NMR (376 MHz, CD3OD) δ −129.6.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08003662B2 |
| Quelldatensatz | uspto-grants-2011_08 |
| ORD ID | ord-2a21113bc3cc4e44aec64cb4eaaece3c |
| Quellennotiz | uspto-grants-2011_08 |